Immunohistochemistry has become an essential ancillary examination for the identification
and classification of carcinomas of unknown primary site (CUPs). Over the last decade, the …

Breast cancer is the most prevalent malignant tumor and main oncologic cause of mortality
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …

Introduction: GATA3 is a transcription factor involved in epithelial cell differentiation. GATA3
immunostaining is used as a diagnostic marker for breast and urothelial cancer but can also …

Carcinoma of unknown primary origin (CUP) is one of the 10 most prevalent malignancies.
CUP patients in whom a site of origin can be ascribed have better outcomes than those in …

GATA3 is a zinc-binding transcription factor that regulates the differentiation of many human
tissue types, including the mammary gland. In surgical pathology, immunohistochemistry for …

Adenocarcinoma is an uncommon malignancy in the urinary bladder which may arise
primarily in the bladder as well as secondarily from a number of other organs. Our aim is to …

Urachal cancer (UrC) is a rare but aggressive cancer. Due to overlapping histomorphology,
discrimination of urachal from primary bladder adenocarcinomas (PBAC) and …

Non‐urothelial carcinomas involving the bladder are uncommon and often diagnostically
challenging. These carcinomas may show squamous, adenocarcinomatous or …

Summary GATA binding protein 3 (GATA-3) is a novel immunohistochemical marker for
urothelial carcinoma (UC); however, few studies have investigated GATA-3's role as a …

This study aimed to evaluate the diagnostic and prognostic roles of GATA-binding protein 3
(GATA3) immunohistochemistry in urothelial carcinoma (UC) using a meta-analysis. We …